Given the recent finding that 1.8% of men below the age of 60 who develop life-threatening COVID-19 have a defective TLR7 [39], there may also be other connections of importance for how CD21low B-cells interact with SARS-CoV-2 vaccines. Here, TLR7 is linked to COVID-19.